(BN) Danone - PA
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: PA (France) | Market Cap: 42.354m EUR | Total Return: 14.9% in 12m
Avg Turnover: 107M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Danone S.A. is a multinational food and beverage provider headquartered in Paris, operating through three primary segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. The company maintains a diverse portfolio of global brands, including Activia, Alpro, Evian, and Aptamil, catering to consumer needs ranging from general hydration to medical nutrition and infant care. Its distribution network spans traditional retail, healthcare institutions, and e-commerce platforms across Europe, North America, and emerging markets.
The business model relies heavily on brand equity and category diversification to mitigate fluctuations in raw material costs, such as milk and plastic resins. As a major player in the Packaged Foods & Meats sub-industry, Danone faces high competition and significant regulatory oversight regarding health claims and nutritional standards. For a deeper look at these competitive dynamics, consider exploring the detailed metrics on ValueRay.
- Resilient demand for specialized medical and infant nutrition segments boosts profit margins
- Portfolio restructuring and brand divestments drive long-term return on invested capital
- Volatile dairy and packaging input costs impact core operating profit performance
- Market share expansion in high-growth North American plant-based and coffee categories
- Regulatory pressure on sugar content and plastic packaging affects global compliance costs
| Net Income: 1.82b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.38 > 1.0 |
| NWC/Revenue: -5.12% < 20% (prev -3.46%; Δ -1.66% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.78b > Net Income 1.82b |
| Net Debt (9.48b) to EBITDA (4.39b): 2.16 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (645.1m) vs 12m ago 0.51% < -2% |
| Gross Margin: 50.62% > 18% (prev 49.70%; Δ 0.91% > 0.5%) |
| Asset Turnover: 60.39% > 50% (prev 60.44%; Δ -0.06% > 0%) |
| Interest Coverage Ratio: 6.09 > 6 (EBIT TTM 3.03b / Interest Expense TTM 498.0m) |
| A: -0.03 (Total Current Assets 13.2b - Total Current Liabilities 14.6b) / Total Assets 45.1b |
| B: 0.41 (Retained Earnings 18.6b / Total Assets 45.1b) |
| C: 0.07 (EBIT TTM 3.03b / Avg Total Assets 45.2b) |
| D: 0.60 (Book Value of Equity 16.9b / Total Liabilities 28.1b) |
| Altman-Z'' = 2.22 = BBB |
| DSRI: 1.04 (Receivables 3.04b/2.92b, Revenue 27.3b/27.4b) |
| GMI: 0.98 (GM 49.70% / 50.62%) |
| AQI: 0.98 (AQ_t 0.56 / AQ_t-1 0.57) |
| SGI: 1.00 (Revenue 27.3b / 27.4b) |
| TATA: -0.04 (NI 1.82b - CFO 3.78b) / TA 45.1b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of June 12, 2026, the stock is trading at EUR 66.00 with a total of 1,263,879 shares traded.
Over the past week, the price has changed by -0.04%,
over one month by -2.83%,
over three months by +11.27% and
over the past year by +14.85%.
Danone has no consensus analysts rating.
P/E Trailing = 23.4043
P/E Forward = 17.1527
P/S = 1.5524
P/B = 2.5166
P/EG = 1.6649
Revenue TTM = 27.3b EUR
EBIT TTM = 3.03b EUR
EBITDA TTM = 4.39b EUR
Long Term Debt = 9.76b EUR (from longTermDebt, last quarter)
Short Term Debt = 5.04b EUR (from shortTermDebt, last quarter)
Debt = 16.1b EUR (from shortLongTermDebtTotal, last quarter) + Leases 937.0m
Net Debt = 9.48b EUR (calculated: Debt 16.1b - CCE 6.57b)
Enterprise Value = 51.8b EUR (42.4b + Debt 16.1b - CCE 6.57b)
Interest Coverage Ratio = 6.09 (Ebit TTM 3.03b / Interest Expense TTM 498.0m)
EV/FCF = 19.03x (Enterprise Value 51.8b / FCF TTM 2.72b)
FCF Yield = 5.25% (FCF TTM 2.72b / Enterprise Value 51.8b)
FCF Margin = 9.98% (FCF TTM 2.72b / Revenue TTM 27.3b)
Net Margin = 6.69% (Net Income TTM 1.82b / Revenue TTM 27.3b)
Gross Margin = 50.62% ((Revenue TTM 27.3b - Cost of Revenue TTM 13.5b) / Revenue TTM)
Gross Margin QoQ = 50.33% (prev 50.90%)
Tobins Q-Ratio = 1.15 (Enterprise Value 51.8b / Total Assets 45.1b)
Interest Expense / Debt = 3.10% (Interest Expense 498.0m / Debt 16.1b)
Taxrate = 29.22% (741.0m / 2.54b)
NOPAT = 2.15b (EBIT 3.03b * (1 - 29.22%))
Current Ratio = 0.90 (Total Current Assets 13.2b / Total Current Liabilities 14.6b)
Debt / Equity = 0.95 (Debt 16.1b / totalStockholderEquity, last quarter 16.9b)
Debt / EBITDA = 2.16 (Net Debt 9.48b / EBITDA 4.39b)
Debt / FCF = 3.48 (Net Debt 9.48b / FCF TTM 2.72b)
Total Stockholder Equity = 16.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 1.82b / Total Assets 45.1b)
RoE = 10.84% (Net Income TTM 1.82b / Total Stockholder Equity 16.8b)
RoCE = 11.41% (EBIT 3.03b / Capital Employed (Equity 16.8b + L.T.Debt 9.76b))
RoIC = 6.29% (NOPAT 2.15b / Invested Capital 34.1b)
WACC = 4.08% (E(42.4b)/V(58.4b) * Re(4.79%) + D(16.1b)/V(58.4b) * Rd(3.10%) * (1-Tc(0.29)))
Discount Rate = 4.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.56 | Cagr: 0.27%
[DCF] Terminal Value 74.54% ; FCFF base≈2.80b ; Y1≈2.66b ; Y5≈2.53b
[DCF] Fair Price = 47.21 (EV 39.8b - Net Debt 9.48b = Equity 30.3b / Shares 641.7m; r=8.35% [WACC [floored]]; 5y FCF grow -6.33% → 2.50% )
EPS Correlation: 34.75 | EPS CAGR: 20.37% | SUE: N/A | # QB: 0
Revenue Correlation: 63.76 | Revenue CAGR: 8.77% | SUE: -0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=3.90 | Chg30d=-0.14% | Revisions=-52% | GrowthEPS=+2.5% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=4.19 | Chg30d=-0.23% | Revisions=-62% | GrowthEPS=+7.5% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: -62%